Navigation Links
Medisafe 1 Technologies to Exhibit at World's Largest Medical Conference
Date:11/10/2010

Medisafe 1 Technologies to Exhibit at World's Largest Medical Conference -- JERUSALEM, November 10, 2010 /PRNewswire-FirstCall/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Biotechnology, Health Care & Hospitals, Medical Equipment, Medical Pharmaceuticals, Trade Show News Click to view news release full screen  

Medisafe 1 Technologies to Exhibit at World's Largest Medical Conference

   

Exhibition at Medica 2010 Conference in Germany November 16-19

JERUSALEM, November 10, 2010 /PRNewswire-FirstCall/ -- Medisafe 1 Technologies Corp. (OTCBB: MFTH), a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that the company will be presenting its technology at the annual Medica 2010 Exhibition in Germany on November 16-19.

Medica is the world's largest annual exhibition in the medical sector, with over 135,000 participants and 4,000 exhibitors arriving from over 100 nations.

The conference attracts users of medical products and services including surgical equipment, implantable devices, physiotherapy products, communications systems and diagnostic equipment. Medica is supported by the Compamed exhibition, which focuses on the suppliers of components and systems to the Medical Technology industry.

"Our participation in the Medica conference is part of our strategic business development initiative to increase awareness about the number of lives that can be saved using advanced locking-device technology on syringes," said Jacob Elhadad, CEO of Medisafe 1 Technologies. "MediSafe 1 Technologies is well positioned to enter the multi-billion dollar medical supply industry, with a particular focus on hospitals, nursing homes and rehabilitation centers worldwide."

About Medisafe 1 Technologies

Medisafe 1 Technologies seeks to effectively prevent unauthorized administration of a drug or medicinal substance by hypodermic needle. Medisafe's patented technology is a medical assembly with a locking mechanism that is intended to ensure the substance cannot be released from the hypodermic needle without positive pre-matching between the substance and its intended patient.

Forward-Looking Statements

This letter contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended and Section 21E of the Securities Exchange Act of 1934 as amended. All forward-looking statements are inherently uncertain, based on current expectations and assumptions concerning future events or future performance of Medisafe 1 Technologies Corp., and its technologies. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release, as actual results may differ materially from those indicated. Medisafe 1 Technologies Corp. public filings may be viewed at http://www.sec.gov.

Contact: Jacob Elhadad CEO +972-524440000 Jacob.elhadad10@gmail.com
'/>"/>

SOURCE Medisafe 1 Technologies Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Medisafe 1 Technologies Presentation on Newly Launched Company Website
2. Medisafe 1 Technologies to Present Syringe Locking-Device Technology at HealthAchieve Conference
3. Medisafe 1 Technologies Successfully Tests Prototype of Patented Syringe Locking Device
4. Medisafe 1 Technologies Corp Notify Shareholders on FINRAs Approval of the 5-1 Stock Dividend
5. Medisafe 1 Technologies Clarifies the PR Issued on September 1 for the Stock Dividend, as a Forward Split of 5-1 in the Form of a Stock Dividend
6. Medisafe 1 Technologies Finalises Contract to Develop Prototype of the Worlds First Ever Medicinal Syringe-Locking Device
7. Medisafe 1 Technologies Granted Eligibility Status by the Depository Trust Company
8. Filtrona Porous Technologies to Display Latest Developments in Bonded Fiber and Polyurethane Foam Component Solutions at the MEDICA / COMPAMED Trade Fair
9. BioSpecifics Technologies Corp. to Present at Lazard Capital Markets 7th Annual Healthcare Conference
10. Reportlinker Adds Proteomics - Technologies, Markets and Companies
11. RF Technologies® Names Paul Reynard Senior Vice President-Sales and Service
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... 22, 2017 Research and Markets has ... by Drug Molecule (Biologic, Small Molecule Drugs), By Route of ... Blockers) Outlook 2022" report to their offering. ... The global psoriasis ... 2016-2022 This report provides a detailed analysis of ...
(Date:2/22/2017)... 2017  Based on its recent analysis of ... recognizes SnooZeal, Inc. with the 2017 European New ... product that intelligently addresses the root causes of ... the clinically proven continuous transmucosal electrical stimulation therapy. ... one of the most accessible anti-snoring products available ...
(Date:2/22/2017)... Feb. 22, 2017  Applied Silver, the maker of SilvaClean®, ... the company,s advisory board. Ms. Barnes is the company,s third ... engineering, legal, and healthcare experts Scott McNealy , ... , J. Tress Ritter , and Leopold Selker ... brings more than three decades of nationally recognized clinical, nursing, ...
Breaking Medicine Technology:
(Date:2/22/2017)... ... 22, 2017 , ... Our high-octane society demands higher stands ... brain. , Power On, a mental performance enhancer from Modus Nutrition, provides scientifically ... capsule contains Cognizin® Citicoline, a branded form of the brain health nutrient citicoline ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... ... its certification exam and eligibility requirements effective with the April 2017 testing period. ... 1995. , “The Care Manager Certified (CMC) exam is periodically re-calibrated to ...
(Date:2/22/2017)... Fla. (PRWEB) , ... February 22, 2017 , ... ... is just as effective on smaller and sometimes harder to reach ones, according ... were presented at the International Stroke Conference in Houston by Ricardo A. Hanel, ...
(Date:2/22/2017)... Washington, D.C. (PRWEB) , ... February 22, 2017 ... ... is being celebrated throughout the country today, as organizations, advocates, and individuals join ... improve detection and treatment access to ultimately save lives. , “Today we mark ...
(Date:2/22/2017)... ... 22, 2017 , ... A product of digesting a micronutrient found in soy ... from eating soy foods, while others do not, a University of Pittsburgh Graduate School ... equol—a substance made by some types of “good” gut bacteria when they metabolize isoflavones ...
Breaking Medicine News(10 mins):